Feverfew 380 mg

product on market Capsule Swanson Premium Brand 🟢 Safety: 100/100
Brand: Swanson Premium Brand
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

380 mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 380mg

Other Ingredients

Gelatin Magnesium Stearate Silica

Label Claims — Verification

❓ All Other
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take one capsule one to two times per day with water or as recommended by your healthcare provider.

⚠️ Warnings & Precautions

Do not use if seal is broken.

Keep out of reach of children.

Warning: Do not take this product if you are pregnant or nursing.

Discontinue use if you experience oral discomfort or skin irritation.

Additional Information

Bringing wellness to the world since 1969

Guaranteed Purity & Potency

Store in a cool, dry place.

Product Details

UPC / SKU 0 87614 11700 3
DSLD Entry Date 2019-11-21
Product Type Botanical
Form Capsule
Brand Swanson Premium Brand
DSLD ID 206385
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
PubMed Cochrane
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
PubMed
View all evidence for Feverfew →

Compare Similar Products

Migra-None Douglas Laboratories 100
White Willow Feverfew 350 mg Eclectic Herb 100
Feverfew
Feverfew GNC Herbal Plus Standardized 100
Feverfew Vitabase 100
Feverfew Max-V Douglas Laboratories 100
View all Feverfew products →
Feverfew research & evidence Best Feverfew rankings All Feverfew products More from Swanson Premium Brand View on NIH DSLD →